Article Details
Retrieved on: 2024-07-17 18:14:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company plans to invest approximately €900 million (US$983 million) to expand its peptide platform at its Colorado, US, site and in Europe.
Article found on: www.biopharminternational.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here